Charles Schwab director sold shares under 10b5-1 plan at ~$96.64
Rhea-AI Filing Summary
Carolyn Schwab-Pomerantz, a director of The Charles Schwab Corporation (SCHW), reported multiple dispositions of Common Stock on 09/04/2025 executed under a Rule 10b5-1 trading plan adopted on August 14, 2024. The filing shows sales of 14,400 shares (reported at a weighted-average price of $96.6377) and 9,600 shares (weighted-average $96.6372), with the transactions executed in multiple trades at prices ranging from $96.235 to $96.93. Following the reported transactions, the filing discloses beneficial ownership positions including 1,449,256.6599 shares held indirectly by a trust and 450,514 shares held indirectly by a spouse as trustee. The Form 4 was signed by an attorney-in-fact on 09/05/2025.
Positive
- Sales executed under a Rule 10b5-1 plan, adopted August 14, 2024, which supports pre-arranged compliance with insider trading rules
- Detailed execution transparency: weighted-average prices and trade price ranges are disclosed
- Significant retained ownership is reported (e.g., 1,449,256.6599 shares indirectly by trust and 450,514 indirectly by spouse as trustee)
Negative
- Dispositions of shares: 14,400 and 9,600 shares were reported sold on 09/04/2025
- Multiple trades were executed across a price range ($96.235 to $96.93), which may complicate precise per-trade analysis
Insights
TL;DR: Routine insider sales under a 10b5-1 plan; transactions were executed across multiple trades at near-$96.6 prices.
The sales reported are dispositions, not exercises or derivative events, and were executed pursuant to a pre-established Rule 10b5-1 plan adopted in August 2024, which typically indicates pre-planned sales rather than opportunistic trading. The weighted-average prices ($96.6377 and $96.6372) and disclosed price ranges provide transparency on execution. The reporting person retains substantial indirect holdings (over 1.4 million shares by trust and ~450k by spouse as trustee), suggesting continued significant economic interest in SCHW.
TL;DR: Governance practices observed: use of 10b5-1 plan and attorney-in-fact signature; disclosure appears complete for the transactions listed.
The filing identifies the reporting person as a director and indicates the trades were made pursuant to a Rule 10b5-1 plan, which supports compliance with insider trading policies. The filing includes weighted-average prices, price ranges, and the plan adoption date, and it is signed by an authorized attorney-in-fact, meeting common disclosure standards. No amendments or indications of unusual trading mechanics are present in the provided content.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 14,400 | $96.6377 | $1.39M |
| Sale | Common Stock | 9,600 | $96.6372 | $928K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (3)
- F1. The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 14, 2024.
- F2. This transaction was executed in multiple trades at prices ranging from $96.235 to $96.93. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3. This transaction was executed in multiple trades at prices ranging from $96.235 to $96.92. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
AI-generated analysis. How Rhea-AI works. Not financial advice.
